Towards the goal of preempting resistance to MDM2 inhibition and eliciting long term disease control, a cell-based screen was conducted to identify compounds that might synergize with MDM2 inhibitors in the inhibition of tumor cell viability. The gene discussed is MDM2; the disease is neoplasm.